Skip to main content
. 2021 Aug;22(8):1139–1150. doi: 10.1016/S1470-2045(21)00288-6

Figure 2.

Figure 2

Effect of trastuzumab versus control on recurrence and mortality

10-year cumulative risk of any recurrence (ie, distant, local, or contralateral; A), breast cancer mortality (B), death without any recurrence (C), and death from any cause (D). Breast cancer mortality rates calculated by total rate (events/woman-years) – rate in women without recurrence. Error bars are 95% CIs. O–E=observed minus expected. RR=rate ratio. V=variance of O–E.